CD4 and neoplasm: Anti-tumor lymphocyte subtypes, like central memory CD4+ and CD8+ T cells, effector memory CD8+ T cells, cytotoxic cells, and monocytes were markedly enriched in patients with the low-risk scores (all P < 0.05).